Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Severe disease or poor pr.. 47% Improvement Relative Risk c19early.org/d Seven et al. Vitamin D for COVID-19 Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Prospective study in Turkey (September - November 2020) Lower severe cases with higher vitamin D levels (p=0.0061) Seven et al., The J. Maternal-Fetal & Neonatal M.., doi:10.1080/14767058.2021.2005564 Favors vitamin D Favors control
Correlation between 25-hydroxy vitamin D levels and COVID-19 severity in pregnant women: a cross-sectional study
Seven et al., The Journal of Maternal-Fetal & Neonatal Medicine, doi:10.1080/14767058.2021.2005564
Seven et al., Correlation between 25-hydroxy vitamin D levels and COVID-19 severity in pregnant women: a cross-sectional.., The Journal of Maternal-Fetal & Neonatal Medicine, doi:10.1080/14767058.2021.2005564
Nov 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Prospective study of 403 pregnant COVID+ hospitalized women in Turkey, showing higher risk of severe disease or poor prognostic factors with vitamin D deficiency.
risk of severe disease or poor prognostic factor, 46.5% lower, RR 0.53, p = 0.006, cutoff 14.5ng/ml, inverted to make RR<1 favor high D levels (≥14.5ng/ml).
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Seven et al., 23 Nov 2021, prospective, Turkey, peer-reviewed, 6 authors, study period September 2020 - November 2020.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Abstract: The Journal of Maternal-Fetal & Neonatal Medicine ISSN: (Print) (Online) Journal homepage: https://www.tandfonline.com/loi/ijmf20 Correlation between 25-hydroxy vitamin D levels and COVID-19 severity in pregnant women: a cross-sectional study B. Seven, O. Gunduz, A. S. Ozgu-Erdinc, Dilek Sahin, O. Moraloglu Tekin & H. L. Keskin To cite this article: B. Seven, O. Gunduz, A. S. Ozgu-Erdinc, Dilek Sahin, O. Moraloglu Tekin & H. L. Keskin (2021): Correlation between 25-hydroxy vitamin D levels and COVID-19 severity in pregnant women: a cross-sectional study, The Journal of Maternal-Fetal & Neonatal Medicine, DOI: 10.1080/14767058.2021.2005564 To link to this article: https://doi.org/10.1080/14767058.2021.2005564 Published online: 23 Nov 2021. Submit your article to this journal Article views: 52 View related articles View Crossmark data Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=ijmf20 THE JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE https://doi.org/10.1080/14767058.2021.2005564 ORIGINAL ARTICLE Correlation between 25-hydroxy vitamin D levels and COVID-19 severity in pregnant women: a cross-sectional study B. Sevena Keskina,b a , O. Gunduza , A. S. Ozgu-Erdinca,b , Dilek Sahina,b , O. Moraloglu Tekina,b and H. L. Department of Ob&Gyn, Ankara City Hospital, Ankara, Turkey; bDepartment of Ob&Gyn, University of Health Sciences, Turkey ABSTRACT ARTICLE HISTORY Objective: To evaluate the relationship between 25-hydroxy vitamin D (25(OH)D) levels and disease severity in hospitalized COVID-19 positive pregnant women Methods: The COVID-19 (þ) pregnant women (confirmed by PCR test) were classified as asymptomatic, mild symptomatic, and severe disease according to their symptoms and laboratory results. Severe COVID-19 criteria were respiratory symptoms and/or findings. The following laboratory results were considered as poor prognostic factors: the number of lymphocytes <800/ml and/or CRP value >10 times the upper limit of the normal range and/or ferritin value >500 ng/ml and/or D-Dimer value >1000 mg/l. The patients were divided into two groups; asymptomatic or mild symptomatic group (Group 1), and severe disease and/or poor prognostic factor group (Group 2). The 25(OH)D levels were compared between groups. ROC curve analysis was used to analyze the cutoff value for vitamin D to predict the severity of COVID-19. Results: 25(OH)D levels were found to be statistically significantly lower in group 2 (15.5 (10.25) ng/ml in Group 1, 13 (12) ng/ml in Group 2, p ¼ .010). The 25(OH)D level under 14.5 ng/ml was associated with severe COVID-19 and/or poor prognostic factors (p ¼ .010). The risk of severe COVID-19 and/or having poor prognostic factors was 1.87 times higher among pregnant women who had 25(OH)D levels below 14.5 ng/ml. This value was found to have 54.1% sensitivity and 61.3% specificity in predicting severe COVID-19 and/or poor prognostic laboratory findings in pregnant women Conclusion: There is a relationship between vitamin D status and the severity of COVID-19 in pregnant women. During the pandemic period, vitamin D supplementation for pregnant women should gain more importance. Received 10 June 2021 Revised 19 September 2021 Accepted 9 November 2021
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit